Deutsche Bank Reiterates Buy Rating on Thermo Fisher (TMO)

Deutsche Bank is out with a research report this afternoon, where it reiterates its Buy rating on Thermo Fisher TMO. The DB analysts cited the company's recent earnings report, noting: 1. “EPS well above Street despite top-line headwinds, driven by margin expansion and tax rate/buyback impact 2. Asia-Pacific growth highlights 4Q performance, with China/India up over 20%. 3. FY11 EPS guidance initiated at $4.00-$4.10, with organic growth expected to be ~4% at the midpoint.” As for valuation, the analysts remarked, “Our PT is based on several methodologies (DCF, P/E comparables), but equates to a P/E of 17x our FY11 operating EPS estimate of $4.25 and 15x our FY12 operating EPS estimate of $4.95, with $74.00 representing the midpoint of our DCF range.”
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsDeutsche BankHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!